Help
Subscribe


Submit Videos to GastroHep Read For FREE - Our full range of review articles
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Emmet Keeffe Profile of Peter Cotton Profile of Roy Pounder

Home

News  
Profiles
Journals
Review Articles
Slide Atlas
Video Clips
Systematic Reviews
Meta-analyses
Guidelines
Online Books
Advanced Digestive Endoscopy
Lectures
Classical Cases
Personal View
Quiz
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links
APT cover

Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS
link to aasld.org

News

Obesity reduces survival in pancreatic cancer

The latest issue of the Journal of the American Medical Association evaluates body mass index, age of onset, and survival in patients with pancreatic cancer.

News image

Obesity has been implicated as a risk factor for pancreatic cancer.

Dr Dong Hui Li and colleagues from Texas, USA evaluated the association of excess body weight across an age cohort and the risk, age of onset, and overall survival of patients with pancreatic cancer.

The team performed a case-control study of 841 patients with pancreatic adenocarcinoma, and 754 healthy individuals frequency matched by age, race, and sex.

The study was conducted at a university cancer center in the United States from 2004 to 2008.

Height and body weight histories were collected by personal interview starting at ages 14 to 19 years and over 10-year intervals progressing to the year prior to recruitment in the study.

The team examined the associations between patients' body mass index  and risk of pancreatic cancer, age at onset, and overall survival  by unconditional logistic regression, linear regression, and Cox proportional hazard regression models, respectively.

The researchers found that individuals who were overweight from the ages of 14 to 39 years or obese.

From the ages of 20 to 49 years had an associated increased risk of pancreatic cancer, independent of diabetes status.

The team found the association was stronger in men by mean body mass index from the ages of 14 to 59 years than in women, and in ever smokers than in never smokers.

The risk of pancreatic cancer based on body mass index was 21% for ever smokers
Journal of the American Medical Association


The population-attributable risk percentage of pancreatic cancer based on the mean body mass index from the ages of 14 to 59 years was 10% for never smokers, and 21% for ever smokers.

Individuals who were overweight or obese from the ages of 20 to 49 years had an earlier onset of pancreatic cancer by 2 to 6 years.

Median age of onset was 64 years for patients with normal weight, 61 years for overweight patients, and 59 years for obese patients.

Compared with those with normal body weight and after adjusting for all clinical factors, individuals who were overweight or obese from the ages of 30 to 79 years or in the year prior to recruitment had reduced overall survival of pancreatic cancer.

Regardless of disease stage and tumor resection status.

Dr Li's team concluded, “Overweight or obesity during early adulthood was associated with a greater risk of pancreatic cancer and a younger age of disease onset.”

“Obesity at an older age was associated with a lower overall survival in patients with pancreatic cancer.”

JAMA 2009: 301(24): 2553-62
29 June 2009

Go to top of page Email this page Email this page to a colleague

 02 September 2010

Advanced search
 02 September 2010 
Risk of colorectal cancer in screenees
 02 September 2010 
Predicting clinical outcomes in liver disease
 02 September 2010 
Recurrent venous thromboembolism
 01 September 2010 
Mortality among undiagnosed celiac disease
 01 September 2010 
Sedation for colonoscopy and EGD in the United States
 01 September 2010 
Natural history of Crohn's disease
 31 August 2010 
Noninvasive prediction of esophageal varices
 31 August 2010 
Determining surveillance of colonic polyps
 31 August 2010 
Medical treatment of Crohn's disease
 30 August 2010 
Trastuzumab for advanced gastric cancer
 30 August 2010 
Beta-blockers in patients refractory ascites
 30 August 2010 
Sustained virological response in HCV
 27 August 2010 
Cognitive functioning and age in senior surgeons
 27 August 2010 
Lifestyle and polyp detection on screening
 27 August 2010 
Antibiotics reduce infection following colectomy
 26 August 2010 
Mesenteric embolization for lower GI bleeding
 26 August 2010 
Follow-up of open vs laparoscopic appendicectomy
 26 August 2010 
Socioeconomic status predicts operative mortality
 25 August 2010 
Wholegrains and risk of colorectal cancers
 25 August 2010 
Alcohol intake and risk of colorectal cancer
 24 August 2010 
Microbiota alteration from donor flora
 24 August 2010 
Complicated hernia with cirrhosis and refractory ascites
 24 August 2010 
Score to identify colectomy risk
 23 August 2010 
Perceptions of medication safety in IBD patients
 23 August 2010 
Laparoscopic peritoneal lavage for perforated diverticulitis
 23 August 2010 
Pentavalent rotavirus vaccine in sub-Saharan Africa
 20 August 2010 
Predicting outcome in acute liver failure
 20 August 2010 
Persistent reflux on PPI therapy
 20 August 2010 
Celiacs without villous atrophy
 19 August 2010 
Centralization improves rectal cancer outcomes
 19 August 2010 
Mortality from peptic ulcer bleeding
 19 August 2010 
Gender variation of IBS symptoms
 18 August 2010 
Eosinophilic esophagitis epidemiology
 18 August 2010 
Care in patients with chronic HCV
 18 August 2010 
Operative mortality in resource-limited settings
 17 August 2010 
Achalasia in a Canadian population
 17 August 2010 
Steatosis as a risk in hepatic resection
 17 August 2010 
Renal failure associated with hepatitis A
 16 August 2010 
Missed cancers after esophagogastroduodenoscopy
 16 August 2010 
Surveillance of dysplasia in ulcerative colitis
 16 August 2010 
Oral bisphosphonates and esophageal cancer
 13 August 2010 
Guidelines for surveillance colonoscopies
 13 August 2010 
Metastatic colorectal patients' outcome
 13 August 2010 
Treatment response in functional bowel disorders
 12 August 2010 
Infliximab dosing on maintenance therapy in Crohn's
 12 August 2010 
Renal transplants in chronic Hep B
 12 August 2010 
Endoscopic resection for Barrett's dysplasia
 11 August 2010 
Treatment for metastatic colorectal cancer
 11 August 2010 
Bacterial infections with pouchitis
 11 August 2010 
Cancer risk in Peutz–Jeghers syndrome
 10 August 2010 
Laparoscopic vs open mesh repair for inguinal hernia
 10 August 2010 
Guidelines to select endoscopy patients
 10 August 2010 
Stability of IBS over time
 09 August 2010 
Determinants of spontaneous Hep B antigen clearance
 09 August 2010 
Gastroprotection with PCI
 09 August 2010 
Capsule endoscopy for Crohn's disease
 06 August 2010 
GERD in minority populations in the USA
 06 August 2010 
Risk factors for incisional hernias
 06 August 2010 
Omental fat and insulin sensitivity
 05 August 2010 
Effects of PPIs on gastric emptying

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2010 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us